Cipla

CIPLA · NSE · INR

1344,00 ₹Variación respecto al cierre anterior: −0,15 %Variación absoluta: −2,00 ₹

Cierre · 1 de octubre de 2026

Perfil de la empresa

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Descripción disponible en inglés.

Datos societarios

Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
País
India
Sede
Cipla House, 400013, Mumbai
Empleados
31.369
Cotización
CIPLA · NSE
Divisa
INR
ISIN
INE059A01026
Sitio web
cipla.com